khiron life sciences news
Corporations medical cannabis sales in 2021 increased to 46 million representing 36 of total revenue. Khiron or the Company TSXV.
TORONTO May 31 2022 CNW - Khiron Life Sciences Corp.
. Khiron Life Sciences Reports 2021 Fiscal Year End Results. A2JMZC a global leader in medical cannabis throughout Latin America and Europe announced today its financial results for the quarter ended March 31 2022 reporting record revenue in the medical cannabis business. Khiron is a leading vertically integrated international medical cannabis corporation with core operations in Latin America and Europe.
PRESS RELEASE PR Newswire. About Khiron Life Sciences Corp. 2021 total revenue increased over 60 YoY to 128 million compared to the previous year.
Related
Find the latest Khiron Life Sciences Corp. News and research before you hear about it on CNBC and others. Khiron Life Sciences Corp.
Finanznachrichtende - November 12 at 1252 PM. Find the latest Khiron Life Sciences Corp. KHRNF is pleased to announce that it has launched an underwritten overnight public offering the Offering of the Companys units each an Unit.
About Khiron Life Sciences CorpKhiron is a leading vertically integrated international medical cannabis corporation with core. Khiron is a leading vertically integrated international medical cannabis corporation with core operations in Latin America and Europe. Through the development of high-quality pharmaceutical products continuous medical education for health professionals and permanent monitoring of the patient in their treatment through the Patient Follow-up Program.
To guarantee a safe effective and responsible prescription of medicinal cannabis in different pathologies through. A2JMZC a global leader in medical cannabis throughout Europe and Latin America announces that it has completed the acquisition. Khiron Life Sciences enters into 10 million bought deal financing.
PharmaDrug is a specialty pharmaceutical company focused on. To Present at the virtual Fall Investor Summit on November 16th-18th. PharmaDrug closes sale of German cannabis assets to Khiron Life Sciences.
Khiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue in Medical Cannabis Seeking Alpha 57d Khiron Life Sciences GAAP EPS of -C003 revenue of C46M. With the sale of its German asset complete PharmaDrug said it continues to advance PD-001 its patented version of cepharanthine towards potential FDA clinical trials on both the oncology and antiviral fronts. KHRNV stock quote history news and other vital information to help you with your stock trading and investing.
KHRNF stock quote history news and other vital information to help you with your stock trading and investing. KHRNF stock at Seeking Alpha. Get the latest news and real-time alerts from Khiron Life Sciences Corp.
Khiron Life Sciences beats on revenue SA News Thu May 27 2021 5. Khiron or the Company TSXV. Khiron or the Corporation TSXV.
The Corporation forecasts Q1 2022 sales revenue of 45 million for the quarter. 2 2022 CNW - Khiron Life Sciences Corp. Khiron Life Sciences Closes Purchase of Pharmadrug Production.
2021 total revenue increased over 60 YoY to 128 million compared to the previous. MT Newswires 08032022 0536. Leveraging medical health clinics and proprietary telemedicine platforms Khiron combines a patient-oriented approach physician education programs scientific product.
Leveraging medical health. 2 2022 0715 AM. Stay up-to-date on all the news from the world of Khiron.
Each Unit will consist of one common share of the Company each a Unit Share. Khiron Life Sciences Reports 2021 Fiscal Year End Results. Khiron is a leading vertically integrated international medical cannabis corporation with core operations in Latin America and Europe.
Leveraging medical health clinics and proprietary telemedicine platforms Khiron combines a patient-oriented approach physician education programs scientific product innovation and cannabis operations expertise to drive. TORONTO June 1 2022 CNW - Khiron Life Sciences Corp. About Khiron Life Sciences Corp.
Khiron Ups Revenue By 60 To 12 8 Million Year Over Year Mugglehead Magazine
Khiron Life Sciences Corp Cve Khrn Ceo On Loi With Copservir Ltda Colombia S Largest Pharmacy Chain C Suite Tv
Khiron Life Sciences Reports First Quarter 2022 Financial Results With Record Revenue In Medical Cannabis Technical420 Technical420
Pharmadrug Inc Closes Sale Of German Cannabis Assets To Khiron Life Sciences Corp
Khiron Life Sciences Is A South American Cannabis Play That Is Flying Under The Radar Technical420 Technical420
News Events Khiron Life Sciences Corp Khrn
Khiron Secures Approval To Sell Three More Cbd Wellness Products Inn
News Events Khiron Life Sciences Corp Khrn
Khiron Launches 12 4 Million Capital Raise At 0 45 Per Unit New Cannabis Ventures
Finance Colombia Khiron Life Sciences Announces Overnight Brokered Offering
Khiron Life Sciences Announces Closing Of 4 6 Million Overnight Brokered Offering Including Full Exercise Of Over Allotment Option
Khiron Life Sciences Doctor Driven Cbd Marketing Strategy Otcmkts Khrnf Seeking Alpha
Khiron New Cannabis Ventures
Khiron Life Sciences Investors Group Mexico Cannabis Marijuana Investir Facebook
News Events Khiron Life Sciences Corp Khrn
Pharmadrug Inc Agrees To Sell German Cannabis Distribution Subsidiary In Exchange For Equity In Khiron Life Sciences And 1 1m Promissory Note
Khiron Life Sciences Robust Latin American Footprint Continues To Grow Like A Weed Technical420 Technical420
Khiron Life Sciences Announces Closing Of 4 6 Million Overnight Brokered Offering Including Full Exercise Of Over Allotment Option
Dixie Brands And Khiron Life Sciences Mutually Agree To Terminate Joint Venture Markets Insider
